These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 177467

  • 1. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
    Miller OV, Gorman RR.
    J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467
    [Abstract] [Full Text] [Related]

  • 2. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M, Zahavi J, Kakkar VV.
    Thromb Haemost; 1984 Oct 31; 52(2):205-9. PubMed ID: 6098048
    [Abstract] [Full Text] [Related]

  • 3. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH, Haslam RJ.
    Mol Pharmacol; 1990 May 31; 37(5):671-81. PubMed ID: 2160060
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of PGE1-stimulated cAMP accumulation in human platelets by thromboxane a2.
    Miller OV, Johnson RA, Gorman RR.
    Prostaglandins; 1977 Apr 31; 13(4):599-609. PubMed ID: 193153
    [Abstract] [Full Text] [Related]

  • 5. The influence of prostaglandin G2 on platelet ultrastructure and platelet secretion.
    Gerrard JM, Townsend D, Stoddard S, Witkop CJ, White JG.
    Am J Pathol; 1977 Jan 31; 86(1):99-116. PubMed ID: 188341
    [Abstract] [Full Text] [Related]

  • 6. The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation.
    Glass DB, Gerrard JM, Townsend D, Carr DW, White JG, Goldberg ND.
    J Cyclic Nucleotide Res; 1977 Feb 31; 3(1):37-44. PubMed ID: 191476
    [Abstract] [Full Text] [Related]

  • 7. Effects of prostaglandins, derivatives of cyclic 3':5'-AMP, theophylline, cholinergic agents and colchicine on clot retraction in dilute platelet-rich plasma and gel-separated platelet test systems.
    Moake JL, Cimo PL, Widmer K, Peterson DM, Gum JR.
    Thromb Haemost; 1977 Aug 31; 38(2):420-8. PubMed ID: 202038
    [Abstract] [Full Text] [Related]

  • 8. On the interrelationship of prostaglandin endoperoxide G2 and cyclic nucleotides in platelet function.
    Claesson HE, Malmsten C.
    Eur J Biochem; 1977 Jun 01; 76(1):277-84. PubMed ID: 195812
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
    Ashida SI, Abiko Y.
    Thromb Haemost; 1979 Apr 23; 41(2):436-49. PubMed ID: 224522
    [Abstract] [Full Text] [Related]

  • 11. Influence of beta 2-glycoprotein-I upon the content of cAMP and cGMP in human blood platelets.
    Nimpf J, Gries A, Wurm H, Kostner GM.
    Thromb Haemost; 1985 Dec 17; 54(4):824-7. PubMed ID: 3003956
    [Abstract] [Full Text] [Related]

  • 12. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets.
    Lam SC, Guccione MA, Packham MA, Mustard JF.
    Thromb Haemost; 1982 Apr 30; 47(2):90-5. PubMed ID: 6285543
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The content and metabolism of cyclic adenosine 3', 5'-monophosphate and cyclic guanosine 3', 5'-monophosphate in adenocarcinoma of the human colon.
    DeRubertis FR, Chayoth R, Field JB.
    J Clin Invest; 1976 Mar 30; 57(3):641-9. PubMed ID: 175089
    [Abstract] [Full Text] [Related]

  • 15. Cyclic nucleotides in platelet function.
    Haslam RJ, Davidson MM, Fox JE, Lynham JA.
    Thromb Haemost; 1978 Oct 31; 40(2):232-40. PubMed ID: 216130
    [Abstract] [Full Text] [Related]

  • 16. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
    Salzman EW.
    Biochim Biophys Acta; 1977 Aug 25; 499(1):48-60. PubMed ID: 196670
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
    Steen VM, Holmsen H.
    Thromb Haemost; 1984 Dec 29; 52(3):333-5. PubMed ID: 6099615
    [Abstract] [Full Text] [Related]

  • 18. Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets.
    Malmsten C, Granström E, Samuelsson B.
    Biochem Biophys Res Commun; 1976 Jan 26; 68(2):569-76. PubMed ID: 175797
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of alpha-tocopherol on platelet membrane function in cystic fibrosis.
    Davis PB, Hubbard VS, Dieckman L, Boat TF, Stern RC, Doershuk CF.
    J Lab Clin Med; 1984 Aug 26; 104(2):203-12. PubMed ID: 6086795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.